Ibudilast Shows Promise for the Treatment of Progressive MS

    loading  Checking for direct PDF access through Ovid

Abstract

A Phase II trial of ibudilast in progressive multiple sclerosis demonstrated a decreased rate of brain atrophy when compared to placebo.

Related Topics

    loading  Loading Related Articles